Literature DB >> 17952285

Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia.

Sérgio M de Almeida1, Edna Nanakanishi, Arnaldo J de Conto, Luciana P Souza, Dario Antonelli Filho, Carlos D Roda.   

Abstract

Central nervous system (CNS) infiltration must be ruled out in patients with known neoplastic diseases and neurological symptoms. It was done a retrospective analysis of 1,948 CSF samples from patients with suspected malignant infiltration in the CNS, in order to evaluate the positivity rate of malignant cells in cerebrospinal fluid (CSF) samples and correlate with cytochemical characteristics. Sixty-two percent of subjects had acute lymphocytic leukemia. Malignant cells were found in 24% of all CSF samples. Subjects with positive malignant cells had predominance of increased levels of CSF total protein (TP), glucose and total cytology (p<0.05). Mean total cell count in this group was 232 (SD 933) cells/mm(3), compared to 9 (SD 93) cells/mm(3) in the group without neoplasic cells (p=0.029). CSF TP specificity was 87% and negative predictive value (NPV) 96%. CSF total cell count specificity 86% and NPV 97%. Although sensitivity and positive predictive value were low. The presence of inflammatory cells and elevated TP found in patients with malignant cells in the CSF can aid in diagnosing CNS neoplasms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952285     DOI: 10.1590/s0004-282x2007000500014

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Bone marrow elements in cerebrospinal fluid: Review of literature with a case study.

Authors:  Anitha Ann Thomas; Felicia Tze Yee Goh
Journal:  Cytojournal       Date:  2013-09-27       Impact factor: 2.091

2.  Evaluation of Sample Quality As Preanalytical Error in Flow Cytometry Analysis in Childhood Acute Lymphoblastic Leukemia.

Authors:  Eszter Szánthó; Bettina Kárai; Gergely Ivády; Sándor Baráth; Marianna Száraz-Széles; János Kappelmayer; Zsuzsanna Hevessy
Journal:  EJIFCC       Date:  2019-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.